These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 13934599)

  • 21. [Triparanol and its pharmacological and therapeutic action on hypercholesteremia and hyperlipemias].
    CASTAGNETO HE
    Prensa Med Argent; 1963 Jan; 50():83-5. PubMed ID: 14019144
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of hypercholesteremia with triparanol and comparison with nicotinic acid.
    ACHOR RW; CHRISTENSEN NA; BERGE KG; MASON HL
    Proc Staff Meet Mayo Clin; 1963 Jan; 38():32-44. PubMed ID: 14010853
    [No Abstract]   [Full Text] [Related]  

  • 23. [FAMILIAL HYPERCHOLESTERINEMIC XANTHOMATOSIS. COLLECTIVE REVIEW, PRESENTATION OF A CASE WITH FAMILY HISTORY].
    BIGOTTI A
    Policlinico Prat; 1964 Oct; 71():1577-85. PubMed ID: 14221346
    [No Abstract]   [Full Text] [Related]  

  • 24. [THE TREATMENT OF HYPERLIPEMIAS AND HYPERCHOLESTEREMIAS WITH D-TRIIODOTHYRONINE].
    SCHWARZ G; HUHNSTOCK K
    Dtsch Med Wochenschr; 1964 Aug; 89():1635-40. PubMed ID: 14172156
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thyroid function tests in major hyperlipemias of metabolic origin].
    de GENNES J; TRUFFERT J
    Rev Atheroscler; 1962; 4():22-34. PubMed ID: 13947153
    [No Abstract]   [Full Text] [Related]  

  • 26. EFFECT OF MER29 (TRIPARANOL) ON HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS IN RABBITS.
    NAKAMURA M; TORII S; HIRAMATSU M; UMEZAKI T; OHTA T; HIRANO J
    Kyushu J Med Sci; 1963 Apr; 14():77-84. PubMed ID: 14043121
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sudden death in a 26 year-old man with essential familial xanthomatous hypercholesteremia].
    Schmitt HJ
    Med Klin; 1968 Oct; 63(40):1582-3. PubMed ID: 4976278
    [No Abstract]   [Full Text] [Related]  

  • 28. Familial hypercholesteremic xanthomatosis: a preliminary report. I. Clinical, electrocardiographic and laboratory considerations.
    GURAVICH JL
    Am J Med; 1959 Jan; 26(1):8-29. PubMed ID: 13606149
    [No Abstract]   [Full Text] [Related]  

  • 29. Familial Hypercholesterolemia with Different types of Xanthomas.
    Khot R; Nagpure K
    J Assoc Physicians India; 2018 Jun; 66(6):86. PubMed ID: 31331144
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure of inhibition of cholesterol biosynthesis to retard atheroma.
    JOSE AD; PEAK HJ
    Br Heart J; 1963 Jan; 25(1):133-6. PubMed ID: 14029686
    [No Abstract]   [Full Text] [Related]  

  • 31. [Discovery of a familial hypercholesteremia of xanthomatous origin on the occasion of etiologic exploration of a recently appeared deafness in a 9-year-old child].
    Bader JC; Canlorbe P; de Gennes JL
    Bull Mem Soc Med Hop Paris; 1965 Oct; 116(13):Suppl:1273-84. PubMed ID: 4955377
    [No Abstract]   [Full Text] [Related]  

  • 32. [TRITON TEST IN THE STUDY OF HYPOCHOLESTEROLEMIZING ACTIVITY OF TRIPARANOL (MER 29)].
    GINOULHIAC E
    Arch Ital Sci Farmacol; 1964 Jan; 14():64-74. PubMed ID: 14292800
    [No Abstract]   [Full Text] [Related]  

  • 33. FAILURE OF CORN OIL AND TRIPARANOL TO PREVENT HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS.
    ARMSTRONG ML; CONNOR WE; MELVILLE RS
    Proc Soc Exp Biol Med; 1963; 113():960-3. PubMed ID: 14073155
    [No Abstract]   [Full Text] [Related]  

  • 34. Essential familial hypercholesterolemia with tendino-cutaneous and cardiovascular xanthomatosis. Clinical and pathological report.
    SANSONE G; BARUFFALDI O; ROMANO C
    Ann Paediatr; 1960 Jul; 195():35-48. PubMed ID: 14441545
    [No Abstract]   [Full Text] [Related]  

  • 35. Essential familial hypercholesterolemia and xanthomatosis; follow-up study of twelve Danish families.
    PIPER J; ORRILD L
    Am J Med; 1956 Jul; 21(1):34-46. PubMed ID: 13339811
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous syndromes produced as side effects of triparanol therapy.
    WINKELMANN RK; PERRY HO; ACHOR RW; KIRBY TJ
    Arch Dermatol; 1963 Mar; 87():372-7. PubMed ID: 14001181
    [No Abstract]   [Full Text] [Related]  

  • 37. [TRIPARANOL, L-TRIIODOTHYRONINE AND 3-PYRIDYL ACETIC ACID IN THE CONTROL OF CHOLESTEROLEMIA. A COMPARATIVE STUDY].
    ARTEAGA A; DIAZ F; TORRES MC; NUNEZ I
    Rev Med Chil; 1963 Jul; 91():502-7. PubMed ID: 14084440
    [No Abstract]   [Full Text] [Related]  

  • 38. TRIPARANOL MYXEDEMA.
    ROBERTS HJ
    J Am Geriatr Soc; 1965 Jun; 13():520-6. PubMed ID: 14299568
    [No Abstract]   [Full Text] [Related]  

  • 39. [EVALUATION OF THE 17-KETOSTEROIDS IN THE URINE OF PATIENTS RECEIVING 1000 MG. OF TRIPARANOL DAILY].
    JAUREGUI GR; DUHART JE; RECCHI NV
    Sem Med; 1963 Aug; 123():375-8. PubMed ID: 14092023
    [No Abstract]   [Full Text] [Related]  

  • 40. MER-29 (TRIPARANOL) AND CATARACT.
    FLAXMAN N
    Med Trial Tech Q; 1963 Dec; 10():11-32. PubMed ID: 14120369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.